Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
49.23
-0.13 (-0.27%)
At close: Apr 17, 2025, 4:00 PM
49.31
+0.09 (0.17%)
After-hours: Apr 17, 2025, 4:31 PM EDT
BMY Market Cap
BMY has a market cap or net worth of $100.17 billion as of April 17, 2025. Its market cap has decreased by -5.07% in one year.
Market Cap
100.17B
Enterprise Value
140.25B
1-Year Change
-5.07%
Ranking
Category
Stock Price
$49.23
Market Cap Chart
Since December 1, 1998, BMY's market cap has decreased from $124.14B to $100.17B, a decrease of -19.31%. That is a compound annual growth rate of -0.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 99.90B | -12.91% |
Dec 31, 2024 | 114.71B | 9.88% |
Dec 29, 2023 | 104.40B | -31.75% |
Dec 30, 2022 | 152.98B | 10.54% |
Dec 31, 2021 | 138.39B | -1.27% |
Dec 31, 2020 | 140.17B | 34.03% |
Dec 31, 2019 | 104.58B | 23.27% |
Dec 31, 2018 | 84.84B | -15.41% |
Dec 29, 2017 | 100.30B | 2.69% |
Dec 30, 2016 | 97.67B | -14.90% |
Dec 31, 2015 | 114.76B | 17.20% |
Dec 31, 2014 | 97.92B | 11.89% |
Dec 31, 2013 | 87.51B | 62.68% |
Dec 31, 2012 | 53.80B | -9.91% |
Dec 30, 2011 | 59.72B | 31.75% |
Dec 31, 2010 | 45.33B | -9.38% |
Dec 31, 2009 | 50.02B | 8.68% |
Dec 31, 2008 | 46.03B | -12.28% |
Dec 31, 2007 | 52.47B | 1.36% |
Dec 29, 2006 | 51.76B | 15.13% |
Dec 30, 2005 | 44.96B | -9.80% |
Dec 31, 2004 | 49.85B | -10.13% |
Dec 31, 2003 | 55.46B | 23.69% |
Dec 31, 2002 | 44.84B | -54.56% |
Dec 31, 2001 | 98.68B | -31.75% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.93B |
UnitedHealth Group | 535.14B |
Johnson & Johnson | 370.90B |
AbbVie | 303.70B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 224.94B |
AstraZeneca | 210.38B |
Novartis AG | 210.23B |